Trademark: 87193653
Status Date
Tuesday, November 5, 2019
Registration Number
5899961
Registration Date
Tuesday, November 5, 2019
Filing Date
Wednesday, October 5, 2016
Published for Opposition
Tuesday, August 20, 2019
1 bioactive peptides for scientific and medical research; chemicals for use in the manufacture of pharmaceuticals and pharmaceutical products; higher fatty acids for use in the field of scientific research, reagents and pharmaceuticals; chemical test paper; unprocessed plastics in the nature of plastics in primary form; medical protein for scientific and medical research purposes
5 clinical medical reagents; pharmaceutical preparations for immunopotentiation and immunostimulation; synthetic peptides for pharmaceutical purposes; pharmaceutical preparations for immunity adjustment; anti-cancer agent containing medical peptides; vaccines to treat cancer containing medical peptides; antitumor drugs containing medical peptides; vaccines to tumor containing medical peptides; antitumor medicine containing medical peptides; medicine which help the active component of the vaccine act on living organism and improve immunity; medical peptide for the treatment of cancer; medical protein arrays for medical diagnosis purposes; medicine, namely, medicine that stabilizes the active ingredient of vaccines, in particular peptides and proteins; medicine that enhance the effectiveness of the active ingredient of a peptide or protein which is an active ingredient of vaccine; medical peptide and protein to be used in the immunotherapy and vaccine therapy to induce and activate the cells involved in antibody and immune response; anti-allergic agent containing medical peptides; medical peptide to be used in the vaccine therapy; medicine, namely, medical adjuvant of the immune adjuvant and enhancing agent which enhances immunity; mineral oil for medical purpose; pharmaceutical preparations for fluid therapies; pharmaceutical preparations and pharmaceutical preparation kits for assessing treatment effect and progress of treatment; pharmaceutical preparations and pharmaceutical preparation kits to identify hereditary risk factors; pharmaceutical preparations for the molecular arrangement diagnosis of biological substances, namely, extracts or analyte and nucleic acid, protein, polypeptide antibodies from organism; antibiotic preparations; anti-viral agents; chemotherapeutics; reagents for clinical medical reagents for use in diagnosing, treating or testing cancer; diagnostic reagents for use in diagnosing, treating or testing cancer; pharmaceutical preparations and other preparations for destroying vermin, fungicides, herbicides; greases for medical purposes; gauze for dressings; empty capsules sold empty for pharmaceuticals; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; antiseptic liquid bandages; semen for artificial insemination; chemical reagents and chemical reagent kits for medical or veterinary purposes, namely, for providing effective genome therapy and identification of protein; chemical reagents and chemical reagent kits for medical or veterinary purposes, namely, for assessing therapeutic effect or progress of treatment; chemical reagent and chemical reagent kits for medical or veterinary purposes, namely, for identification of the inheritable risk factors; chemical reagents for the molecular arrangement diagnosis of biological substances, in particular, extracts or analyte of nucleic acid, protein, and polypeptide antibodies from organism
35 business administration and office work, namely, supporting preparation of documents, paperwork used when representing application and performing other official procedure relating to clinical trial of pharmaceutical products in a medical institution; business administration relating to clinical trial of pharmaceutical products in a medical institution; business services, namely, medical business management analysis and business consultancy; business management analysis and business consultancy; business services, namely, medical business management information; information services relating to medical office administration; office functions, namely, filing, in particular documents or magnetic tape relating to clinical trial; business administration for others, namely, providing business assistance to others in the operation of data processing apparatus namely, computers, typewriters, and other similar office machines relating to clinical trial; advertising services; publicity services; promoting the goods and services of others through the administration of sales and promotional incentive schemes, namely, incentive award programs involving trading stamps; marketing research; providing information concerning commercial sales; import-export agencies; document reproduction; regulatory submission management, namely, assisting others in preparing and filing applications for approval of pharmaceuticals; business intermediary services relating to the matching of pharmaceutical companies with medical institutions conducting clinical trials of pharmaceutical products and other medical institutions
42 conducting clinical trials for others; conducting clinical trials for pharmaceutical products; providing information about the results of clinical trials for pharmaceutical products; medical laboratory services; scientific research in the field of clinical conducting clinical trials for others; conducting clinical trials for pharmaceutical products; providing information about the results of clinical trials for pharmaceutical products; medical laboratory services; scientific research in the field of clinical trial of pharmaceutical products; providing information relating to clinical trial of pharmaceutical products; scientific research in the field of genomes, life science and pharmaceutical preparations; providing advice, explanation and information relating to scientific research in the field of genomes, life science and pharmaceutical preparations; scientific research, namely, testing, research and establishing a method of treatment in the field of method of treatment based on expression of gene and protein, and, based on activation of gene and protein; scientific research, namely, research, test and inspection in the field of therapeutic reagent for antibodies, antisense drugs, peptide, protein and gene; consulting and research of product development in the field of biomedicine, genetics and pharmacodynamics; test and development of product development in the field of biomedicine, genetics and pharmacodynamics; development, testing, inspection and advice regarding the development, testing, and inspection of preparations and other pharmaceutical preparations in the field of biomedicine, life science, including genes, and biology; testing, inspection and research of in the field of pharmaceuticals, cosmetics and foodstuffs; providing information in the field of testing, inspection and research in the field of pharmaceuticals; providing temporary use of non-downloadable software for data information processing in the field of pharmaceuticals; providing temporary use of non-downloadable software for data information processing; designing of machines, apparatus, instruments or systems composed of such machines, apparatus and instruments; computer software design, computer programming, or maintenance of computer software technological advice relating to installation of software on computers, automobiles and industrial machines; testing of and research on machines, apparatus and instruments for pharmaceutical products; rental of computers; rental of laboratory apparatus and instruments
44 providing medical information relating to medical practice, medical services, nursing care, health and healthcare; consultancy and counselling relating to medical practice in the nature of the provision of medical services, medical services, nursing care, health and healthcare; medical services; providing medical information; physical examination; dentistry; preparation and dispensing of medications; dietary and nutritional guidance; rental of medical apparatus and instruments; information services relating to medical assistance, namely, information about home health aides
45 licensing of technology, namely, pharmaceutical production technology; licensing of research and development, namely, licensing of intellectual; legal consultancy relating to industrial property rights; consultancy relating to intellectual property management, in particular on licensing of software for management of intellectual property; providing legal information on industrial property rights; licensing of industrial property rights; granting of licenses to others for the use of industrial property rights; legal services regarding the management of industrial property rights; intellectual property consultancy services for universities and research institutions; licensing of intellectual property; legal consultancy relating to the licensing of intellectual property; agencies for copyright licensing; legal services relating to social insurance claims
Dec 9, 2020
Automatic Update Of Assignment Of Ownership
Nov 5, 2019
Registered-Principal Register
Aug 20, 2019
Official Gazette Publication Confirmation E-Mailed
Aug 20, 2019
Published For Opposition
Jul 31, 2019
Notification Of Notice Of Publication E-Mailed
Jul 18, 2019
Case Returned To Examination
Jul 18, 2019
Notice Of Allowance Cancelled
Jun 22, 2019
Petition To Director - Change Basis - Granted
Jun 20, 2019
Assigned To Petition Staff
Jun 17, 2019
Teas Change Of Correspondence Received
May 30, 2019
Notice Of Approval Of Extension Request E-Mailed
May 28, 2019
Extension 3 Granted
May 28, 2019
Extension 3 Filed
May 28, 2019
Teas Extension Received
May 28, 2019
Teas Petition To Amend Basis Received
Nov 29, 2018
Notice Of Approval Of Extension Request E-Mailed
Nov 27, 2018
Extension 2 Granted
Nov 27, 2018
Extension 2 Filed
Nov 27, 2018
Teas Extension Received
May 9, 2018
Notice Of Approval Of Extension Request E-Mailed
May 7, 2018
Extension 1 Granted
May 7, 2018
Extension 1 Filed
May 7, 2018
Teas Extension Received
Nov 28, 2017
Noa E-Mailed - Sou Required From Applicant
Oct 3, 2017
Official Gazette Publication Confirmation E-Mailed
Oct 3, 2017
Published For Opposition
Sep 13, 2017
Notification Of Notice Of Publication E-Mailed
Aug 31, 2017
Law Office Publication Review Completed
Aug 18, 2017
Assigned To Lie
Aug 7, 2017
Approved For Pub - Principal Register
Aug 7, 2017
Examiner's Amendment Entered
Aug 7, 2017
Notification Of Examiners Amendment E-Mailed
Aug 7, 2017
Examiners Amendment E-Mailed
Aug 7, 2017
Examiners Amendment -Written
Jul 28, 2017
Previous Allowance Count Withdrawn
Jul 25, 2017
Withdrawn From Pub - Og Review Query
Jul 7, 2017
Approved For Pub - Principal Register
Jul 6, 2017
Examiner's Amendment Entered
Jul 6, 2017
Notification Of Examiners Amendment E-Mailed
Jul 6, 2017
Examiners Amendment E-Mailed
Jul 6, 2017
Examiners Amendment -Written
May 24, 2017
Examiner's Amendment Entered
May 24, 2017
Notification Of Examiners Amendment E-Mailed
May 24, 2017
Examiners Amendment E-Mailed
May 24, 2017
Examiners Amendment -Written
Apr 27, 2017
Teas/Email Correspondence Entered
Apr 26, 2017
Correspondence Received In Law Office
Apr 26, 2017
Teas Response To Office Action Received
Oct 28, 2016
Notification Of Non-Final Action E-Mailed
Oct 28, 2016
Non-Final Action E-Mailed
Oct 28, 2016
Non-Final Action Written
Oct 24, 2016
Assigned To Examiner
Oct 20, 2016
Teas Voluntary Amendment Received
Oct 11, 2016
New Application Office Supplied Data Entered In Tram
Oct 8, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
